Long-Term Safety of Crisaborole Ointment 2% in Children and Adults With Mild-To-Moderate Atopic Dermatitis

Pediatrics - United States
doi 10.1542/peds.2018-2420jj
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Academy of Pediatrics (AAP)

Related search

Evaluation of a Pseudoceramide Moisturizer in Patients With Mild-To-Moderate Atopic Dermatitis

Dermatology and Therapy
Dermatology
2014English

Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults

Oncotarget
Oncology
2017English

605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Sustained Efficacy and Safety of Pimecrolimus Cream 1% When Used Long-Term (Up to 26 Weeks) to Treat Children With Atopic Dermatitis

Pediatrics
Child HealthPediatricsPerinatology
2008English

New Cosmetic Formulation for the Treatment of Mild to Moderate Infantile Atopic Dermatitis

Children
2019English

Supportive Therapy for Atopic Dermatitis in Children and Adults

Klinicheskaya Dermatologiya i Venerologiya
DermatologyInfectious Diseases
2017English

Oral Immunotherapy to Peanut in Children With Mild and Moderate Peanut Allergy Results in Long Term Tolerance

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

615 Dupilumab Elicits Rapid and Sustained Improvements in Itch in Adults With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Phase 1 Study of Crisaborole in Japanese Healthy Volunteers and Patients With Atopic Dermatitis

Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy